Shopping Cart 0
Cart Subtotal
USD 0

Vanderbilt University Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Vanderbilt University Medical Center (VUMC), a subsidiary of Vanderbilt University is a healthcare service provider that offers patient care, research and bio-medical education. The center's services include adult emergency services, case management, corporate health services, adult psychiatry, diabetes research, disease management, dialysis clinic, and home care services. It provides patient care in the areas including heart and heart surgery, ear, nose and throat, endocrinology, gynaecology, cancer, kidney disease, respiratory disorders, and urology. VUMC offers bio-medical research and post doctoral education programs. The center also provides cancer wellness program to promote health and well being for people affected by cancer. It operates through its hospitals, health care centers, and rehabilitation centers located in its campus. VUMC is headquartered in Nashville, Tennessee, the US.

Vanderbilt University Medical Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Vanderbilt University Medical Center, Medical Devices Deals, 2012 to YTD 2018 10

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Bayer and Vanderbilt University Medical Center Enter into Research Agreement 12

Cancer Prevention Pharma Enters into Partnership with National Cancer Institute and Vanderbilt University Medical Center 13

Human Vaccines Project and Vanderbilt University Medical Center Enters into Agreement with Illumina 14

Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 15

Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16

Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 17

Vanderbilt University Medical Center-Key Competitors 18

Vanderbilt University Medical Center-Key Employees 19

Vanderbilt University Medical Center-Locations And Subsidiaries 20

Head Office 20

Recent Developments 21

Government and Public Interest 21

Sep 06, 2018: Team's findings could spur new treatments for type 2 diabetes 21

Sep 06, 2018: Nicotine patch shows promise in treating late-life depression 22

Aug 30, 2018: Team isolates antibodies that neutralize GI?bug norovirus 24

Aug 21, 2018: PCORI Board approves USD 85 million to support new studies on opioids, cancer and other high-burden conditions 25

Jun 29, 2018: DBS treatment may slow tremor progression in early-stage Parkinson's patients 26

May 07, 2018: Records point to drug-drug interaction 28

Feb 01, 2018: Study tracks therapy to slow idiopathic pulmonary fibrosis 29

Jan 18, 2018: New nerve stimulation treatment helps ease sleep apnea 31

Jan 18, 2018: Vanderbilt University Medical Center secures grant to address the challenges of limb problems in peripheral artery disease 33

Jan 18, 2018: Rising obesity rates in South leading to rapid increase in diabetes 35

Jan 04, 2018: Asthma study may point to potential new therapeutic approach 37

Jan 04, 2018: Research sheds light on how microtubules are assembled 38

Dec 07, 2017: Searching out pancreatic cancer risk 39

Dec 05, 2017: DNA damage repair: molecular insights 40

Nov 16, 2017: Study may point to new treatment approach for ASD 41

Nov 09, 2017: Amoxicillin alone better choice for pediatric pneumonia: study 42

Nov 09, 2017: Study to explore cancer survivorship, sexuality 44

Nov 02, 2017: Liquid biopsies help reveal lung cancer mutations 45

Jul 13, 2017: New approach for staph-related skin abscesses explored 46

Jan 09, 2017: USD 2.5 Million in New Grants Advance Clinical Trials of Alzheimer's Treatments 47

Product News 49

Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 49

Oct 05, 2017: Major international study testing therapy to prevent spread of HIV 50

Jul 12, 2018: Team explores diabetes drug's ability to treat RSV?infection 51

Apr 13, 2017: Vanderbilt University Medical Center: Trial to test implantable device to ease gastroesophageal reflux 53

Jan 18, 2018: Investigators eye new target for treating movement disorders 54

Other Significant Developments 55

Aug 01, 2018: A protein could be key to preserving heart function in Duchenne muscular dystrophy 55

Appendix 56

Methodology 56

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Vanderbilt University Medical Center, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Key Facts 2

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Vanderbilt University Medical Center, Deals By Therapy Area, 2012 to YTD 2018 9

Vanderbilt University Medical Center, Medical Devices Deals, 2012 to YTD 2018 10

Vanderbilt University Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bayer and Vanderbilt University Medical Center Enter into Research Agreement 12

Cancer Prevention Pharma Enters into Partnership with National Cancer Institute and Vanderbilt University Medical Center 13

Human Vaccines Project and Vanderbilt University Medical Center Enters into Agreement with Illumina 14

Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 15

Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16

Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 17

Vanderbilt University Medical Center, Key Competitors 18

Vanderbilt University Medical Center, Key Employees 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Vanderbilt University Medical Center, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.